These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 4272269)
21. [Analysis of the effectiveness of anticoagulant and fibrinolytic therapy in myocardial infarct]. Kheĭnonen IM; Makeeva GK; Kholodilina IM Klin Med (Mosk); 1969 Jul; 47(7):41-8. PubMed ID: 5385087 [No Abstract] [Full Text] [Related]
22. [Certain aspects of the tactics of anticoagulant therapy in myocardial infarct]. Anisimov VK Ter Arkh; 1969 Apr; 41(4):94-9. PubMed ID: 5379418 [No Abstract] [Full Text] [Related]
23. Heparin and streptokinase. Sobel BE Cardiovasc Drugs Ther; 1997 Apr; 11(2):97-100. PubMed ID: 9140686 [No Abstract] [Full Text] [Related]
24. Treatment of myocardial infarction. Fearnley GR Br Med J; 1971 Aug; 3(5772):473. PubMed ID: 5567773 [No Abstract] [Full Text] [Related]
25. [Clinical evaluation of various methods of treatment of patients with myocardial infarct]. Riabov SI; Veresova AA; Dubetskaia MG; Kirsanov AI; Nilov VM; Rogozina ES; Teliatnikova VA Kardiologiia; 1969 May; 9(5):117-21. PubMed ID: 4241030 [No Abstract] [Full Text] [Related]
26. Myocardial infarction. Bradley JP N Z Med J; 1999 May; 112(1088):191. PubMed ID: 10391649 [No Abstract] [Full Text] [Related]
27. [Anticoagulant drugs. Fibrinolytic drugs]. Cristea E Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1976; 20(2):105-7. PubMed ID: 133400 [No Abstract] [Full Text] [Related]
28. [On fibrinolytic therapy of intravascular thrombosis (review of the literature)]. Gritsiuk AI Ter Arkh; 1967 May; 39(5):12-9. PubMed ID: 4237762 [No Abstract] [Full Text] [Related]
29. Fibrinolytic therapy of myocardial infarction: theory and clinical results. Ruegsegger P Angiologica; 1968; 5(2):136-45. PubMed ID: 5661002 [No Abstract] [Full Text] [Related]
30. [Anisoylated plasminogen streptokinase complex during the acute phase of myocardial infarction. Results of a multicenter double-blind study versus heparin]. Cassagnes J; Bassand JP; Machecourt J; Lusson JR; Anguenot T; Borel E; Vacher D; Denis B; Maurat JP; Jallut H Arch Mal Coeur Vaiss; 1990 Apr; 83(4):453-60. PubMed ID: 2111665 [TBL] [Abstract][Full Text] [Related]
31. [On the treatment of myocardial infarct with special reference to fibrinolytic substances]. Heinrich HG Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):38-45. PubMed ID: 4189370 [No Abstract] [Full Text] [Related]
32. Use of alpha-adrenoceptor antagonist dihydroergotoxin in experimental anticoagulant and fibrinolytic therapy. Kalishevskaya TM; Golubeva MG; Bashkov GV Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):157-61. PubMed ID: 2459012 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of patients with acute coronary insufficiency with thrombolytic preparations (fibrinolysin and thrombolytin)]. Khalfen ESh; Orlova NP Ter Arkh; 1968 Dec; 40(12):48-52. PubMed ID: 4247402 [No Abstract] [Full Text] [Related]
35. Aspirin augmentation of the efficacy of thrombolysis. O'Donnell CJ; Jonas MA; Hennekens CH Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015 [No Abstract] [Full Text] [Related]
36. [Medical treatment of myocardial infarct in the acute phase]. Trigano JA; Torresani J; Jouve A Rev Prat; 1974 Dec 7-11; 24(55):5019-20, 5023-4, 5029-30 passim. PubMed ID: 4155526 [No Abstract] [Full Text] [Related]
37. [Clinical-experimental findings in the fibrinolytic therapy of fresh myocardial infarct]. Breddin K; Ehrly AM; Krzywanek HJ Verh Dtsch Ges Inn Med; 1972; 78():1039-41. PubMed ID: 4665456 [No Abstract] [Full Text] [Related]
38. [Principles of anticoagulant therapy in myocardial infarct]. Krug H Pol Tyg Lek; 1972 Mar; 27(13):498-501. PubMed ID: 4553473 [No Abstract] [Full Text] [Related]
39. [Antithrombotic treatment of myocardial infarct]. Rasche H Z Allgemeinmed; 1973 Oct; 49(28):1319-25. PubMed ID: 4756668 [No Abstract] [Full Text] [Related]